Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | TP53 Y220C |
Therapy | CP-31398 |
Indication/Tumor Type | hepatocellular carcinoma |
Response Type | sensitive |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
TP53 Y220C | hepatocellular carcinoma | sensitive | CP-31398 | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with CP-31398 resulted in decreased proliferation, increased apoptosis, and cell-cycle arrest in a hepatocellular carcinoma cell line harboring TP53 Y220C in culture (PMID: 26250460). | 26250460 |
PubMed Id | Reference Title | Details |
---|---|---|
(26250460) | CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo. | Full reference... |